Skip to content

Nutritional therapy and gut inflammation in adults with newly diagnosed Crohn's disease

To demonstrate patterns and extent of changes in faecal inflammatory markers consequent to exclusive enteral nutrition.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12613000163707
Enrollment
38
Registered
2013-02-11
Start date
2013-05-01
Completion date
2015-12-04
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purpose of the study is to investigate whether the benefits of exclusive enteral nutrition (a liquid diet) seen in paediatric populations can be replicated in adult populations. The study hypothesis is that a liquid diet changes markers of gut inflammation in adults with newly diagnosed Crohn’s disease leading to clinical and biochemical remission of Crohn’s disease.

Interventions

8 week treatment with exclusive enteral nutrition (liquid diet) instead of corticosteroid therapy. The liquid diet consists of commercially available a polymeric nutrition formula. It will meet all of the participants calorie and nutrient requirements, no food or fluid other than water is allowed. It is to be taken orally, or via nasogastric tube if not tolerated orally, 6 - 8 times per day based on individual requirements.

Sponsors

University of Otago
Lead SponsorUniversity

Study design

Allocation
Non-randomised trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
16 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

newly diagnosed ileal or ileo-colonic Crohn's disease aged 16 - 40 years willing to take part able to attend multiple appointments

Exclusion criteria

active pyschological disorder possibly requires abdominal surgery

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026